Panbela Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Panbela Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2013 to Q3 2024.
  • Panbela Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -302 %, a 66% decline year-over-year.
  • Panbela Therapeutics, Inc. annual Return On Assets for 2023 was -173 %, a 66% increase from 2022.
  • Panbela Therapeutics, Inc. annual Return On Assets for 2022 was -508 %, a 450% decline from 2021.
  • Panbela Therapeutics, Inc. annual Return On Assets for 2021 was -92.4 %, a 29.7% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -302 -120 -66% Jul 1, 2024 Sep 30, 2024
Q2 2024 -270 -94.5 -53.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -208 +235 +53.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -173 +335 +66% Oct 1, 2023 Dec 31, 2023
Q3 2023 -182 +199 +52.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -175 +103 +36.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -443 -342 -341% Jan 1, 2023 Mar 31, 2023
Q4 2022 -508 -416 -450% Oct 1, 2022 Dec 31, 2022
Q3 2022 -381 -308 -420% Jul 1, 2022 Sep 30, 2022
Q2 2022 -278 -203 -272% Apr 1, 2022 Jun 30, 2022
Q1 2022 -100 -37.9 -60.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -92.4 -21.1 -29.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -73.3 +23.5 +24.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -74.8 +72.2 +49.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -62.4 +184 +74.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -71.3 +172 +70.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -96.8 +169 +63.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -147 +215 +59.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -246 +118 +32.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -243 +137 +36.1% Oct 1, 2019 Dec 31, 2019
Q3 2019 -266 +310 +53.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -362 +175 +32.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -364 +73 +16.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -380 +198 +34.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 -576 -4.37 -0.76% Jul 1, 2018 Sep 30, 2018
Q2 2018 -537 +18.4 +3.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 -437 +77.2 +15% Jan 1, 2018 Mar 31, 2018
Q4 2017 -577 -243 -72.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -572 -365 -176% Jul 1, 2017 Sep 30, 2017
Q2 2017 -556 -375 -208% Apr 1, 2017 Jun 30, 2017
Q1 2017 -514 -251 -95.6% Jan 1, 2017 Mar 31, 2017
Q4 2016 -334 +122 +26.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -207 +300 +59.1% Jul 1, 2016 Sep 30, 2016
Q2 2016 -180 +634 +77.9% Apr 1, 2016 Jun 30, 2016
Q1 2016 -263 +377 +59% Jan 1, 2016 Mar 31, 2016
Q4 2015 -456 -63.6 -16.2% Oct 1, 2015 Dec 31, 2015
Q3 2015 -507 -175 -53% Jul 1, 2015 Sep 30, 2015
Q2 2015 -815 -755 -1262% Apr 1, 2015 Jun 30, 2015
Q1 2015 -640 -587 -1109% Jan 1, 2015 Mar 31, 2015
Q4 2014 -393 -354 -919% Oct 1, 2014 Dec 31, 2014
Q3 2014 -331 -324 -4594% Jul 1, 2014 Sep 30, 2014
Q2 2014 -59.8 Apr 1, 2014 Jun 30, 2014
Q1 2014 -52.9 Jan 1, 2014 Mar 31, 2014
Q4 2013 -38.5 Oct 1, 2013 Dec 31, 2013
Q3 2013 -7.06 Jul 1, 2013 Sep 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.